It seems the federal government has finally decided to join the rest of us in this century. After what felt like an eternity of dragging their feet, the powers that be in Washington have officially bumped cannabis down a few pegs on their danger list. The Trump administration has moved state licensed medical marijuana and FDA approved products from Schedule I to Schedule III.
For those who do not spend their days memorising government drug schedules, this is a big deal. Schedule (I) has long been the home of substances deemed to have zero medical value and a high risk of causing trouble, placing cannabis right next to heroin. Moving it to Schedule (III) puts it in the company of things like ketamine and anabolic steroids. It turns out that when you stop acting like a stern Victorian schoolmaster, you might actually notice that people have been using the stuff for medical reasons for quite some time.
A Taxing Situation
Do not pop the champagne just yet. This is liberalisation, not full legalisation. If you were hoping to see dispensaries popping up on every corner with federal approval, you will have to keep waiting. This order specifically covers state licensed medical programmes and FDA approved products. It is not an open invitation for a national smoke out.
However, the industry is already cheering. By moving to Schedule (III), these businesses might finally get a break from some truly punishing tax rules. The old code basically treated them like they were selling illicit goods, which made it nearly impossible to write off basic business costs. This change helps them keep more of their money, which is why the stock market reacted with a bit of excitement.
The Psychedelic Side Quest
The administration did not stop at cannabis. The President also signed an order to speed up the research process for psychedelics like ibogaine. It is fascinating to watch the government go from treating these substances like absolute poison to suddenly wanting to understand their medical potential. Maybe they finally realised that blocking research does not stop people from using these things. It just stops us from knowing how they work.
We should also remember that this shift did not happen overnight. It is the result of years of pressure from voters and states who simply got tired of waiting for the federal government to catch up.
If you are wondering what this means for your daily life, the answer is probably not much. The real change happens in labs, courtrooms, and tax offices. But it is still a sign that the iron grip of prohibition is finally starting to slip.
Did you find this update on the shifting winds of drug policy interesting? Please share this article with your friends. Also, do not forget to sign up for our newsletter to keep informed of future stories.
UK, now your turn!
Related topics: North America
